The phosphorylated retinoid X receptor-α promotes diethylnitrosamine-induced hepatocarcinogenesis in mice through the activation of β-catenin signaling pathway.
The phosphorylated retinoid X receptor-α promotes diethylnitrosamine-induced hepatocarcinogenesis in mice through the activation of β-catenin signaling pathway.
复制标题
DOI:
10.1093/carcin/bgab099
复制
发表时间:
2022-04-25
期刊:
影响因子:
4.7
通讯作者:
中科院分区:
文献类型:
--
作者:
Previous studies have shown that phosphorylation of the retinoid X receptor-α (RXRα) is associated with the development of hepatocellular carcinoma (HCC). However, these findings were revealed using HCC cell lines that express phosphorylated-RXRα (p-RXRα) proteins; therefore, it remains unclear whether p-RXRα affects hepatocarcinogenesis in vivo. Therefore, to investigate the biological function of p-RXRα in vivo, we developed a doxycycline-inducible ES cell line and transgenic mouse, both of which overexpress the phosphomimetic mutant form of RXRα, T82D/S260D, in a doxycycline-dependent manner. We found that the development of liver tumors, especially high-grade adenoma and HCC, was enhanced in diethylnitrosamine (DEN)-treated T82D/S260D-inducible mice. Moreover, the increased incidence of liver tumors in the transgenic mice was attributable to the promotion of cell cycle progression. Interestingly, the expression of β-catenin protein and its target gene cyclin D1 was elevated in the liver tumors of DEN-treated T82D/S260D-inducible mice, concurrent with increased cytoplasmic and nuclear β-catenin protein expression, indicating its stabilization and transcriptional activation. These results indicate that p-RXRα promotes DEN-induced hepatocarcinogenesis in mice through the activation of the β-catenin signaling pathway, suggesting that p-RXRα may serve as a possible therapeutic target for HCC. p-RXRα plays a key role in chemically induced hepatocarcinogenesis in mice. The fact that the abnormal phosphorylation of RXRα is involved in liver carcinogenesis in vivo suggests that p-RXRα may serve as a possible therapeutic target for HCC.
登录
查看更多内容
影响因子:
24.5
作者:
Chen J;Rajasekaran M;Xia H;Zhang X;Kong SN;Sekar K;Seshachalam VP;Deivasigamani A;Goh BK;Ooi LL;Hong W;Hui KM
通讯作者:
Hui KM
影响因子:
4.3
作者:
Liu LJ;Xie SX;Chen YT;Xue JL;Zhang CJ;Zhu F
通讯作者:
Zhu F
影响因子:
14.9
作者:
KELMAN, Z;ODONNELL, M
通讯作者:
ODONNELL, M
影响因子:
158.5
作者:
Llovet, Josep M.;Ricci, Sergio;Bruix, Jordi
通讯作者:
Bruix, Jordi
影响因子:
168.9
作者:
Bruix, Jordi;Qin, Shukui;Han, Guohong
通讯作者:
Han, Guohong